Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.575 EUR | +0.32% | -5.12% | -60.62% |
Sales 2024 * | 650K 705K | Sales 2025 * | 31.4M 34.05M | Capitalization | 47.63M 51.66M |
---|---|---|---|---|---|
Net income 2024 * | -18M -19.52M | Net income 2025 * | -1M -1.08M | EV / Sales 2024 * | 146 x |
Net Debt 2024 * | 47.5M 51.51M | Net Debt 2025 * | 17.7M 19.2M | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
-3.18
x | P/E ratio 2025 * |
-52.5
x | Employees | 62 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.24% |
Latest transcript on Sequana Medical N.V.
1 day | +0.32% | ||
1 week | -5.12% | ||
Current month | +10.92% | ||
1 month | +12.50% | ||
3 months | -40.57% | ||
6 months | -37.99% | ||
Current year | -60.62% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 15-12-31 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 22-07-18 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 18-11-07 |
Ids van der Weij
BRD | Director/Board Member | - | Nov. 09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.575 | +0.32% | 19,610 |
24-05-23 | 1.57 | +4.67% | 37,818 |
24-05-22 | 1.5 | -13.04% | 377,386 |
24-05-21 | 1.725 | +0.29% | 61,877 |
24-05-20 | 1.72 | +3.61% | 59,308 |
Real-time Euronext Bruxelles, May 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.62% | 51.7M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- SEQUA Stock